Inmed Pharmaceuticals Inc. buy Bankster
Start price
21.01.25
/
50%
€6.45
Target price
21.01.26
-
Performance (%)
-54.42%
End price
31.01.25
€2.94
Summary
This prediction ended on 31.01.25 with a price of €2.94. The BUY prediction by Bankster for Inmed Pharmaceuticals Inc. performed very badly with a performance of -54.42%. Bankster has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Inmed Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% |
According to Bankster what are the pros and cons of Inmed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Bankster for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Buy Inmed Pharmaceuticals Inc.